Insilico Medicine named five humans, including CEO Alex Zhavoronkov, as inventors on a patent for a pulmonary fibrosis drug that its generative AI platform proposed, highlighting a US legal rule that …
Vivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has built HIVE, modular robotic labs that grow 20 kinds of human tissue and autonomously dose and monitor them, aiming t…
AI-driven drug discovery has attracted US$60 billion since 2019, with 175 AI-originated programmes entering human trials, yet none have won FDA approval; however, AI-discovered molecules clear Phase I…
Demis Hassabis, co-founder of Google DeepMind, will become chief scientist at Alphabet, succeeding Jeff Dean, who is leaving for a start-up. Hassabis will focus on artificial general intelligence (AGI…
DeepMind CEO Demis Hassabis is stepping aside from day-to-day leadership to become chair of DeepMind and chief scientist at Alphabet, with Koray Kavukcuoglu taking over as senior vice president report…
Google and Alphabet CEO Sundar Pichai announced that Demis Hassabis will become Chair of Google DeepMind and Chief Scientist of Alphabet, while Koray Kavukcuoglu will step up as SVP of Google DeepMind…
Google has disbanded its AlphaFold protein-structure prediction team, reassigning most founders to its Gemini chatbot project and prompting about a quarter of the team to resign, according to the Fina…
Google DeepMind has disbanded the dedicated research team behind AlphaFold, the Nobel Prize-winning protein-structure prediction system, according to a Financial Times report. Nobel laureate John Jump…
Google has dismantled the original AlphaFold team, reassigning many researchers to Gemini and Isomorphic Labs, while several key members including Nobel laureate John Jumper left for Anthropic, accord…
Google DeepMind dissolved the team that built AlphaFold, but the AlphaFold Protein Structure Database remains operational and is hosted by EMBL-EBI, not Google, with no deprecation or sunset date. The…
Google DeepMind has dismantled the team behind its Nobel Prize-winning AlphaFold protein-folding AI, reassigning most original authors and losing nearly a quarter of them, including Nobel co-winner Jo…
Google DeepMind has disbanded its Nobel Prize-winning AlphaFold team, with roughly 25% of the original research authors departing the company, including Nobel laureate John Jumper who joined Anthropic…
Google Deepmind has dismantled the team behind its Nobel Prize-winning AlphaFold protein-folding AI, reassigning most original authors to projects involving Gemini, enzyme design, nuclear fusion, and …
Google DeepMind has disbanded its Nobel Prize-winning AlphaFold team, with about a quarter of researchers leaving the company, including lead John Jumper who joined Anthropic in June 2026. The Financi…
Isomorphic Labs, the Alphabet spinoff, released IsoDDE on February 10, a unified drug design engine that achieves a 50% success rate on the hardest molecular prediction tasks, outperforming AlphaFold …
Apple Inc. has sent document retention letters to dozens of OpenAI employees as part of a widening trade secrets lawsuit that claims over 400 former Apple employees now work at OpenAI, threatening the…
Isomorphic Labs unveiled the Isomorphic Labs Drug Design Engine (IsoDDE), a unified computational drug-design system that more than doubles the accuracy of AlphaFold 3 on a challenging protein-ligand …
Google DeepMind philosopher Iason Gabriel works to anticipate the ethical fallout of AI, bridging the gap between AI safety and AI ethics. His 2020 paper on values and alignment argues that choosing w…
Google DeepMind has launched a bioresilience programme to use AI to prevent, detect and respond to biological threats, the London lab and its sister company Isomorphic Labs announced in a joint blog p…
Google DeepMind and Isomorphic Labs have announced a joint initiative on bioresilience, using AI to predict and defend against biological threats, building on AlphaFold technology. Isomorphic Labs, fo…